Jump to content
View in the app

A better way to browse. Learn more.
99NICU

A full-screen app on your home screen with push notifications, badges and more.

To install this app on iOS and iPadOS
  1. Tap the Share icon in Safari
  2. Scroll the menu and tap Add to Home Screen.
  3. Tap Add in the top-right corner.
To install this app on Android
  1. Tap the 3-dot menu (⋮) in the top-right corner of the browser.
  2. Tap Add to Home screen or Install app.
  3. Confirm by tapping Install.

Prof. Ann Hellström and Dr. Jiří Dušek speak about ARA & DHA Supplementation in Extremely Preterm Infants

https://99nicu.org/events/event/402-prof-ann-hellstr%C3%B6m-and-dr-ji%C5%99%C3%AD-du%C5%A1ek-speak-about-ara-dha-supplementation-in-extremely-preterm-infants/

Event created by Neobiomics

Neobiomics and 99NICU are pleased to invite you to the upcoming NeoMega36® Webinar, where leading experts in neonatology and ophthalmology will share the latest scientific evidence and clinical experiences on ARA and DHA supplementation in
extremely preterm infants.


Date: 14 October 2025
Time: 15.30 – 16.30 CET
Register Here: https://us06web.zoom.us/meeting/register/-o0RnQR3S_arS5EfX6Zs9A

Topic: ARA & DHA Supplementation in Extremely Preterm Infants- Scientific Evidence and Clinical Experiences of NeoMega36®


What to expect:

  • Prof. Ann Hellström will present findings from the Mega Donna Mega trial and its substudies, key research that contributed to the development of NeoMega36®.

  • Dr. Jiří Dušek, one of the first users of NeoMega36®, will share his experiences, explain why his team decided to implement
    it their NICU, and discuss outcomes and key learnings after one year of practical use.

  • Introduction to NeoMega36® – supporting the normal vision development in extremely preterm infants, an innovative solution
    containing arachidonic acid (ARA) and docosahexaenoic acid (DHA).

Speakers:
Prof. Ann Hellström
Mega Donna Mega Trial and its substudies
Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomised Clinical Trial
Professor of Pediatric Ophthalmology, Sahlgrenska University Hospital, Gothenburg, Sweden


Dr. Jiří Dušek
First-Year Experience from Our NICU
ARA and DHA Supplementation to Support Normal Visual Development in Extremely Premature Infants
Head of the Department of Neonatology, Hospital Nemocnice České Budějovice, Czech Republic


Dr. Stefan Johansson
Moderator
Chief Medical  Officer & Co-founder at Neobiomics
Associate Professor and Consultant Neonatologist at Sachsska University Hospital, Stockholm, Sweden


Don’t miss out – join our expert-led discussion on ARA & DHA and their
impact on vision development in extremely preterm infants!
Register Here: https://us06web.zoom.us/meeting/register/-o0RnQR3S_arS5EfX6Zs9A
We look forward to your participation!
Best regards,

Team Neobiomics

  • Download Event
    •
    https://99nicu.org/events/event/402-prof-ann-hellstr%C3%B6m-and-dr-ji%C5%99%C3%AD-du%C5%A1ek-speak-about-ara-dha-supplementation-in-extremely-preterm-infants/

    Recommended Comments

    There are no comments to display.

    Create an account or sign in to comment

    Configure browser push notifications
    Chrome (Android)
    1. Tap the lock icon next to the address bar.
    2. Tap Permissions → Notifications.
    3. Adjust your preference.
    Chrome (Desktop)
    1. Click the padlock icon in the address bar.
    2. Select Site settings.
    3. Find Notifications and adjust your preference.